Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy for human brain disorders.

Olle Lindvall1, Zaal Kokaia

  • 1Laboratory of Neurogenesis and Cell Therapy, Section of Restorative Neurology, Wallenberg Neuroscience Center, University Hospital, Lund, Sweden. olle.lindvall@med.lu.se

Kidney International
|October 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrochemical Detection of Neuronal Injury in Cell Culture Samples: A Cost-Effective Biosensor for Neurofilament Light Sensing.

Biosensors·2026
Same author

Time-dependent changes in monocyte subsets and gene expression patterns are associated with long-term recovery in patients with ischemic stroke.

Research square·2026
Same author

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease.

BMJ open·2025
Same author

"Oxygen tone" drives stage-specific OPC phenotypes for cell-based stroke therapy.

Stem cell reports·2025
Same author

Brain Organoid Transplantation: A Comprehensive Guide to the Latest Advances and Practical Applications-A Systematic Review.

Cells·2025
Same author

Type I Interferon Signaling Augments Autoimmunity in Neuromyelitis Optica Spectrum Disorder.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Stem cell therapies offer hope for brain disorders like Parkinson's and stroke. Further research is crucial to determine optimal cell sources and integration methods for effective clinical treatments.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Stem cell transplantation and endogenous stem cell mobilization are potential therapies for brain disorders.
  • The adult brain can generate new neurons in response to injury, and neurons for transplantation can be derived from stem cells.
  • Current clinical development of stem cell therapies for neurological diseases is in its preliminary stages.

Purpose of the Study:

  • To evaluate the potential of stem cell-based therapies for brain disorders.
  • To highlight the challenges and necessary research directions for clinical translation.
  • To underscore the need for cautious, scientifically-grounded clinical trials.

Main Methods:

  • Investigating various stem cell sources, including embryonic and adult stem cells from different tissues.

Related Experiment Videos

  • Researching methods to control stem cell proliferation and differentiation into specific neuronal types.
  • Studying the integration of transplanted cells into existing neural networks.
  • Optimizing functional recovery in animal models that mimic human brain diseases.

    • Main Results:

    • Demonstrated generation of transplantable neurons from stem cells in culture.
    • Confirmed endogenous neurogenesis in the adult brain following injury.
    • Identified key areas requiring further research for clinical application.

    Conclusions:

    • Significant progress has been made, offering hope for future cell-based treatments for intractable brain diseases.
    • Further research is essential to address fundamental questions regarding stem cell source, control, integration, and functional recovery.
    • Proceeding with caution and avoiding premature clinical trials is paramount to ensure patient safety and therapeutic efficacy.